Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study. Vasc Health Risk Manag • June 18, 2014
Critical evaluation of the efficacy and tolerability of azilsartan. Vasc Health Risk Manag • September 5, 2012
Critical review of cancer risk associated with angiotensin receptor blocker therapy. Vasc Health Risk Manag • June 2, 2012
Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism. Vasc Health Risk Manag • February 2, 2012
Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital. Vasc Health Risk Manag • January 19, 2012
Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag • October 30, 2009
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag • June 21, 2009
Safety and efficacy of rosiglitazone in the elderly diabetic patient. Vasc Health Risk Manag • June 20, 2009